Frontiers in neurology · 2026
Factors associated with orthostatic hypotension presence and severity in multiple system atrophy: a cross-sectional study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Kaige, Xu Xuan, Wang Yao, Zhang Han, Wang Liye, Wang Yunxian, Wei Meiqi, Li Nannan, Chen Zhigang
Аннотация
BACKGROUND: The factors governing the presence and severity of orthostatic hypotension (OH) in multiple system atrophy (MSA) may differ. We investigated factors independently associated with OH and severe OH in MSA, and assessed the consistency of these associations across subtypes.
METHODS: We examined the clinical data of 242 MSA patients who had blood pressure evaluations to assess OH. We analyzed the clinical data of MSA patients with and without OH, as well as those with mild and severe OH, focusing on clinical characteristics and brain MRI features to identify factors associated with OH presence and severe OH.
RESULTS: OH was present in 136 patients (56.2%). MSA-C subtype (OR = 2.42, 95% CI = 1.33-4.43, p = 0.004), probable MSA (OR = 2.68, 95% CI = 1.49-4.80, p = 0.001), and higher UMSARS-I scores (OR = 1.10, 95% CI = 1.03-1.17, p = 0.005) were independently associated with the presence of OH. Among OH-positive patients, male (OR = 2.57, 95% CI = 1.21-5.44, p = 0.014) and higher NMSS scores (OR = 1.06, 95% CI = 1.02-1.11, p = 0.009) were independently associated with severe OH, whereas MSA subtype was not. Subgroup analyses showed directionally consistent associations for male sex and NMSS across MSA-C and MSA-P subgroups. The association between NMSS and severe OH was statistically significant in the MSA-C subgroup (OR = 1.09, 95% CI = 1.03-1.15, p = 0.004), whereas the remaining subgroup estimates did not reach statistical significance. No neuroimaging marker was associated with OH.
CONCLUSION: Factors associated with OH presence differed from those associated with severe OH in MSA. MSA-C subtype, diagnostic certainty, and UMSARS-I score were associated with OH presence, whereas male sex and NMSS burden were associated with severe OH.
METHODS: We examined the clinical data of 242 MSA patients who had blood pressure evaluations to assess OH. We analyzed the clinical data of MSA patients with and without OH, as well as those with mild and severe OH, focusing on clinical characteristics and brain MRI features to identify factors associated with OH presence and severe OH.
RESULTS: OH was present in 136 patients (56.2%). MSA-C subtype (OR = 2.42, 95% CI = 1.33-4.43, p = 0.004), probable MSA (OR = 2.68, 95% CI = 1.49-4.80, p = 0.001), and higher UMSARS-I scores (OR = 1.10, 95% CI = 1.03-1.17, p = 0.005) were independently associated with the presence of OH. Among OH-positive patients, male (OR = 2.57, 95% CI = 1.21-5.44, p = 0.014) and higher NMSS scores (OR = 1.06, 95% CI = 1.02-1.11, p = 0.009) were independently associated with severe OH, whereas MSA subtype was not. Subgroup analyses showed directionally consistent associations for male sex and NMSS across MSA-C and MSA-P subgroups. The association between NMSS and severe OH was statistically significant in the MSA-C subgroup (OR = 1.09, 95% CI = 1.03-1.15, p = 0.004), whereas the remaining subgroup estimates did not reach statistical significance. No neuroimaging marker was associated with OH.
CONCLUSION: Factors associated with OH presence differed from those associated with severe OH in MSA. MSA-C subtype, diagnostic certainty, and UMSARS-I score were associated with OH presence, whereas male sex and NMSS burden were associated with severe OH.